Integrated Platform for Sample Storage,
Management, and Use
Dedicated to the standardized, high-quality preservation of human genetic resource materials, ensuring sample traceability and centralized storage, this approach serves as the cornerstone for effectively promoting sample utilization and sharing. It boasts a capacity to preserve 15 million sample tubes.
More +
Focus on intelligent monitoring and management of the entire lifecycle of human genetic resource information, enabling full-chain traceability, data mining, integration, and open sharing of sample information. The first phase will feature private cloud storage capacity for 30 PB of sample-related information.
More +
Focusing on the in-depth development and utilization of human genetic resources, we are expanding our business into areas such as cell centers, third-party medical testing laboratories, multi-omics platforms, and regional training centers, thereby establishing smooth channels for sample transformation and application.
More +About Us
Wuhan National Human Genetic Resources Biobank (hereinafter referred to as the "Biobank") As a key "Life and Health Industry Innovation Platform" jointly established by Hubei Province, Wuhan City, and the East Lake High-tech Development Zone, the Biobank is a comprehensive, application-oriented human genetic resources repository. It is dedicated to leveraging multi-channel, multi-category samples and large-scale multi-modal data to promote open sharing and clinical translation. Adhering to the principles of "no raw samples leaving the repository, no raw data leaving the domain, data availability without visibility.
Learn more +
Sample storage capacity
Data storage capacity
Computing power
News
New Product Launch | CAR-T Product Services
2026-05-20
New Year's Day | Wuhan sample library is recognized as a high-tech enterprise
According to the relevant provisions of the Administrative Measures for the Identification of High-tech Enterprises (GKFH [2016] No. 32) and the Guidelines for the Identification and Management of High-tech Enterprises (GKFH [2016] No. 195), the National Leading Community Office for the Identification and Management of High-tech Enterprises issued the "Notice on the Filing and Publicity of the Fifth Batch of High-tech Enterprises Identified by the Hubei Provincial Accreditation Agency in 2022", Wuhan Biological Sample Bank Co., Ltd. (hereinafter referred to as "Wuhan Sample Bank") is recognized as a high-tech enterprise. High-tech enterprises refer to resident enterprises that have been registered in China (excluding Hong Kong, Macao and Taiwan) for more than one year by continuously carrying out research and development and transformation of technological achievements, forming core independent intellectual property rights of enterprises, and carrying out business activities on this basis within the "High-tech Fields Supported by the State". It is a knowledge-intensive and technology-intensive economic entity. In the future, Wuhan sample bank will further promote the conservation and utilization of human genetic resources and the transformation of achievements, and promote the innovation of biotechnology sources, so that Wuhan sample bank will become a "national" brand platform with strong "hematopoietic" ability, and help the high-quality development of the big health industry.
2023-01-13
Good news | Wuhan sample library won two qualification evaluations!
1、 Wuhan sample library was approved by Wuhan Enterprise R&D Center On November 11, 2022, Wuhan Municipal Bureau of Science and Technology issued the Notice on Publishing the First Batch of Wuhan Enterprise Research and Development Center Filing List in 2022 (WK [2022] No. 98), and the enterprise research and development center of Wuhan Biological Sample Bank Co., Ltd. was recognized at the municipal level. Wuhan Enterprise Research and Development Center (hereinafter referred to as "R&D Center") is a relatively independent scientific and technological research and development specialized organization established within the enterprise, mainly engaged in the research and development of new technologies, new products, new processes and new materials, and promoting the industrialization and application of scientific and technological achievements. Wuhan Biological Sample Library will effectively strengthen the construction and management of the research and development center, give full play to the supporting role of the research and development center in improving the technological innovation ability, and make positive contributions to the economic and social development of Wuhan. 2、 Wuhan sample library won the recognition of "Optics Valley Gazelle" enterprise in 2022 On November 4, 2022, the Science and Technology Innovation Bureau of Wuhan East Lake High-tech Zone issued the Notice on Publicizing the List of Enterprises to Be Identified as "Optics Valley Gazelle" in 2022, and Wuhan Biological Sample Library was successfully listed. "Gazelle enterprises" refer to small and medium-sized enterprises that have crossed the Death Valley and entered a high growth period with the support of technological innovation or business model innovation. The scope of identification is mainly that the industrial field conforms to the development direction of national and provincial strategic emerging industries, covering emerging industries, new generation information technology, biological health, artificial intelligence, financial technology, energy conservation and environmental protection, consumption upgrading and other fields, also known as "high growth enterprises". Such enterprises have the characteristics of "specialized, refined, special and new". The growth rate, scientific and technological content and industrial prospects are the three core indicators for the selection of "Gazelle Enterprises". In the future, Wuhan sample library will "base itself on Hubei, radiate the central region, and look around the world", and contribute to accelerating the research and development of innovative drugs, promoting the development of translational medicine, and leading the industrial transformation and upgrading.
2022-11-18
Partner
关注我们：
Message：
Tel：
在线客服添加返回顶部
右侧在线客服样式 1,2,3 1
图片alt标题设置： Wuhan Biobank
表单验证提示文本： The content cannot be empty!
循环体没有内容时： Sorry, no matching content was found.
CSS / JS 文件放置地
